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Abstract
Background:  TILLING (Targeting Induced Local Lesions in Genomes) is a reverse genetic
technique based on the use of a mismatch-specific enzyme that identifies mutations in a target gene
through heteroduplex analysis. We tested this technique in Caenorhabditis elegans, a model
organism in which genomics tools have been well developed, but limitations in reverse genetics
have restricted the number of heritable mutations that have been identified.
Results: To determine whether TILLING represents an effective reverse genetic strategy for C.
elegans we generated an EMS-mutagenised population of approximately 1500 individuals and
screened for mutations in 10 genes. A total of 71 mutations were identified by TILLING, providing
multiple mutant alleles for every gene tested. Some of the mutations identified are predicted to be
silent, either because they are in non-coding DNA or because they affect the third bp of a codon
which does not change the amino acid encoded by that codon. However, 59% of the mutations
identified are missense alleles resulting in a change in one of the amino acids in the protein product
of the gene, and 3% are putative null alleles which are predicted to eliminate gene function. We
compared the types of mutation identified by TILLING with those previously reported from
forward EMS screens and found that 96% of TILLING mutations were G/C-to-A/T transitions, a
rate significantly higher than that found in forward genetic screens where transversions and
deletions were also observed. The mutation rate we achieved was 1/293 kb, which is comparable
to the mutation rate observed for TILLING in other organisms.
Conclusion: We conclude that TILLING is an effective and cost-efficient reverse genetics tool in
C. elegans. It complements other reverse genetic techniques in this organism, can provide an allelic
series of mutations for any locus and does not appear to have any bias in terms of gene size or
location. For eight of the 10 target genes screened, TILLING has provided the first genetically
heritable mutations which can be used to study their functions in vivo.
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Background
Caenorhabditis elegans is a well-established model system
(reviewed by Hodgkin [1]) that is increasingly being used
for genetic and molecular investigations into conserved
biological processes, including those involved in human
disease [2-5]. Although simple in structure, C. elegans is
comparable to higher animals in development and forms
most of the major tissue types that are important to verte-
brate physiology. Indeed, in a comparison of 18,452 C.
elegans protein sequences against human EST databases,
83% (15,344 sequences) of the C. elegans sequences were
found to have human homologues [6].
Because the sequence of the complete C. elegans genome
has been available since 1998, bioinformaticians have
been presented with ample opportunity to mine the data,
and a plethora of genomic and proteomic information is
accessible to researchers wishing to build upon this infor-
mation [7]. Powerful in silico techniques have also been
developed for the analysis of genome sequence informa-
tion and are used in the prediction of gene function,
expression and interaction [5,8,9]. Despite the exciting
possibilities flowing from these studies, the testing of pre-
dictions made in silico relies largely on the existence of effi-
cient reverse genetic approaches that target specific genes
or classes of genes in vivo. In vitro techniques such as yeast
two-hybrid analysis [10] and microarray analysis [11]
have also been used to generate an abundance of valuable
data about gene expression and protein interactions but,
like the data generated in silico, these data need to be ver-
ified in vivo.
C. elegans has approximately 19,800 protein-coding genes
and 12,000 of these have been conserved over the 100
million years since this species has diverged from the
related nematode Caenorhabditis briggsae, indicating that
they are likely important functional genes [12]. In spite of
this fact, however, only about 3,400 genes in C. elegans
have mutant alleles available for genetic and biochemical
analysis to ascertain their function and importance [13].
High-throughput reverse genetics is an ideal way of gener-
ating mutations in the remaining 16,400 genes and sev-
eral such approaches have been developed for the
nematode each of which has advantages and drawbacks
that affect the applicability or efficiency of the technique
as a tool for probing gene function on a genomic scale.
Currently, the most efficient and popular method to dis-
rupt the activity of a gene in C. elegans is the technique of
RNA interference (RNAi) [14]. Large-scale RNAi screens
have demonstrated that the function of a diverse popula-
tion of genes with roles in many biological processes can
be disrupted by the injection of double-stranded RNA
(dsRNA) directly into the gonad [15], by soaking the nem-
atodes in a dsRNA solution [16], or by feeding the nema-
todes bacteria expressing dsRNA [17,18]. These same
studies, however, have also documented that the pheno-
types resulting from the RNAi treatment often depend on
the method of delivery. In addition, the RNAi technique
cannot replace classical genetic analysis because the phe-
notypic effects are transient and not heritable, making
classical genetic interaction studies impossible.
Another effective reverse-genetic technique that is being
used successfully in C. elegans is mutagenesis with tri-
methylpsoralen and ultraviolet radiation (TMP/UV) fol-
lowed by detection of gene knockouts by PCR. This is
currently the method of choice for obtaining heritable
loss-of-function mutations in C. elegans but there are also
drawbacks to this approach. First, the limitations of the
detection method necessitate using a high dosage of
mutagen which requires multiple rounds of outcrossing
to remove accompanying background mutations. In addi-
tion, missense alleles cannot be isolated and large dele-
tion events may result in the loss of function from more
than one locus simultaneously. Finally, although the rea-
son for this is unclear, mutations in certain genes have
been more difficult to obtain than in others.
Transposon-insertion mutagenesis is another tool that is
available to the C. elegans community [19,20] but it shares
many of the limitations discussed for the previous tech-
niques in addition to some that are specific to this
approach such as the fact that small genes are less likely to
be targets of transposon insertion and certain regions of
the genome may vary in the frequency at which trans-
posons insert. The mutagenic effect of Tc1 insertions can
also sometimes be circumvented by innate compensation
mechanisms that allow spicing around the transposon.
A recently reported study of biolistic transformation in C.
elegans  indicates that homologous recombination of
introduced DNA is also possible in this species [21] but,
in spite of the potential of this technique to provide the
long-sought ability to perform site-directed mutagenesis
in C. elegans, the low success rate and the fact that an elab-
orate microparticle bombardment set-up is required,
make it unlikely that this procedure will soon become effi-
cient enough for high-throughput reverse genetics.
As a result of drawbacks in currently used reverse genetic
techniques, the pace of research into biological processes
in C. elegans is still largely dictated by the probability of
obtaining a mutant of any given gene and, thus, new tech-
niques are needed to complement those previously
described. TILLING (Targeting Induced Local Lesions in
Genomes) is a relatively novel reverse genetics technique
based on the use of a mismatch-specific enzyme that will
identify mutations in any target gene through heterodu-
plex analysis [22]. The technique involves PCR amplifica-BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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tion of a target gene or region of DNA using fluorescently
labelled primers, followed by digestion with an enzyme
that specifically cleaves at the site of a mismatch such as
that induced by ethylmethanesulfonate (EMS) mutagene-
sis (see Figure 1). The sizes of the cleavage fragments
resolved on polyacrylamide gels reveal the approximate
position of the mutation within the amplicon. We report
here on a pilot project to test the use of this technology in
C. elegans: we have constructed and arrayed a mutagenised
population and used it to isolate mutations in 10 different
genes. On the basis of these data we conclude that TILL-
ING is as effective and cost-efficient in C. elegans as it has
been shown to be in other species in which it has been
tested [23-29].
Results and Discussion
Efficiency of TILLING in C. elegans
To determine whether TILLING represents an effective
reverse genetic strategy for C. elegans we generated and
arrayed an EMS-mutagenised population of approxi-
mately 1500 individual animals (see below) and screened
for mutations in 10 genes varying in size from 788 base
pairs (bp) to 9112 bp. A region of approximately 1500 bp
from each gene was examined and a total of 71 novel
mutations were identified by TILLING, thus providing
multiple mutant alleles for each gene (Table 1). Some of
the mutations we identified are predicted to be silent,
either because they are in non-coding DNA or because
they affect the third bp of a codon which does not change
the amino acid encoded by that codon. However, 59% of
the mutations we identified are missense alleles resulting
in a change in one of the amino acids in the protein prod-
uct of the gene, and 3% are nonsense alleles resulting
from the insertion of a premature stop codon into the
coding region of the gene, or in the elimination of a con-
served splice junction site. These data demonstrate the
efficacy of TILLING in C. elegans.
Comparison of forward and reverse genetics with EMS 
mutagenesis
A C. elegans population was constructed for this TILLING
project using the mutagen EMS (Figure 2). EMS was cho-
sen because it has been shown to be an effective mutagen
in this species and because it is known to generate prima-
rily single bp mutations which can be identified using
TILLING [23,30-34].
A survey of Wormbase [7] was performed in order to
examine the type of molecular lesion induced by EMS in
C. elegans to ensure that the majority of these mutations
are, indeed, small intergenic lesions of the type that can be
identified by TILLING (see Additional File 1 for a list of
alleles). Two hundred and thirteen alleles from 51 differ-
ent genes whose molecular sequence was known were
selected randomly from the database. All of the mutations
were reported to be identified in screens of EMS-treated
animals. Ninety three percent of the 213 alleles examined
from Wormbase were found to be single bp mutations.
Eighty seven percent were G/C-to-A/T transitions, six per-
cent were other single bp mutations, and seven percent of
the mutations reported were deletions that ranged in size
from 88 bp to 2.3 kb.
In our TILLING experiment, 68 of the 71 independent
mutations identified (96%) were G/C-to-A/T transitions
and the remaining three mutations were A/T-to-T/A or G/
Table 1: List of TILLING targets, sizes of amplicons and number and type of mutations identified for each gene.
Gene Name Description Gene
Size (bp)
PCR
Size (bp)
1Prev.
alleles
2Prev.
strains
3Mis-
sense
3Null 3Silent 3Total
*C05C10.5 Hypothetical protein 788 1175 0 0 2 1 3
mel-32 C05D11.11 Serine hydroxyl-methyl-transferase 1600 1500 16 1 4 1 2 7
mus-81 C43E11.2 Endonuclease MUS81 2530 1171 1 0 4 3 7
xpf-1 C47D12.8 Structure-specific endonuclease ERCC1-XPF 9112 1452 0 0 5 3 8
*F25H2.13 Helicase of the DEAD superfamily 4985 1499 1 0 5 4 9
htp-3 F57C9.5 HIM-3 paralogue 2598 1452 1 1 5 5 10
*M03C11.2 Helicase of the DEAD superfamily 5943 1490 1 0 4 1 5
cki-2 T05A6.2 Hypothetical protein 1555 1569 0 0 7 1 2 10
mdf-2 Y69A2AR.30 Spindle assembly checkpoint protein 4461 1466 1 0 1 5 6
htp-2 Y73B6BL.2 HIM-3 paralogue protein 2 1199 1451 0 0 5 1 6
Totals 14225 42 2 27 71
* Gene name not assigned
1 Number of mutant alleles listed in Wormbase [7] as existing prior to this study.
2 Number of mutant strains available from the Caenorhabditis Genetic Stock Center.
3 Number of mutations of this type identified in this TILLING study.
Missense mutations alter the amino acid sequence of the encoded protein. Null mutations refer to mutations that convert an amino acid codon into 
a premature stop codon, or that alter a conserved splice junction and result in premature truncation of the protein product of the gene. Silent 
mutations are changes that do not affect the protein product of the gene. These include mutations in introns or intergenic sequences, and mutations 
that alter the third bp of a codon in such a way that it does not change the amino acid encoded by that codon.BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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Overview of the TILLING procedure Figure 1
Overview of the TILLING procedure. Pooled DNA is amplified using fluorescently tagged, gene-specific primers. The forward 
and reverse primers are labelled with different fluorophors that label both ends of the fragment. The amplified products are 
denatured by heating and then allowed to cool slowly so that they randomly re-anneal. Heteroduplex molecules form when 
mutant and wild-type PCR products anneal together, and these then become targets for a single-strand-specific nuclease found 
in Celery Juice Extract (CJE). The nuclease cleaves these heteroduplex fragments at one of the two strands, 3' to the site of the 
mismatch in the DNA. The PCR products that retain one of the labelled primers can then be detected on polyacrylamide dena-
turing LI-COR gels. Individuals with a mutation in the gene of interest are identified by the smaller cleavage fragment seen on 
the gel as well as the wild-type product. Because the nuclease cleaves either of the two strands randomly, cleavage products 
can be detected in both the IRD700 and IRD800 channels of the gel image. The position of the mutation within the PCR ampli-
con can be calculated from the size of the two fragments carrying the forward, IRD700-labeled primer, and the reverse, 
IRD800-labeled primer. Grey bands on the gel are thought to result from partial PCR products and aid in sizing of mutant 
bands.
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C-to-T/A transversions (Table 2). This percentage of G/C-
to-A/T transitions is significantly higher than that found
in forward genetic screens and probably reflects the fact
that many EMS-induced lesions are not identified using
classical genetic screens because they do not have an effect
on phenotype. The frequency of transversions seen with
TILLING in our screen is similar to the frequency found in
forward genetic screens using EMS in C. elegans (6%), but
significantly lower than the number of transversions
mutations reported in a small Drosophila TILLING project
(16%) [29], and significantly higher than the number
found in Arabidopsis where greater than 99% of mutations
sequenced were G/C-to-A/T transitions [23].
Three of the mutant strains we generated in this study,
CN579, CN1162 and CN1574 carried two point muta-
tions within the target gene. In each case, one of the sec-
ond-site mutations was in non-coding DNA and so
presumably would not affect the phenotype of the ani-
mals carrying the linked mutation. Second-site mutations
have been reported in forward genetic screens of EMS-
treated worms as well. A case in point is the molecular
analysis of unc-52 mutations and intragenic suppressor
alleles [35]. Two of the 19 mutations sequenced in the
unc-52 study carried a second site mutation less than 400
bp upstream of the primary mutation. One of these sec-
ond-site mutations was a single bp transition, and the
other was a 311 bp deletion. In both cases, the second-site
mutations were not found to affect the phenotype of the
animals carrying them. Second-site mutations have also
been found in EMS screens of yeast [33] and Drosophila
[34], and so presumably reflect some common DNA
repair mechanism that is induced upon EMS damage.
Deletions are another type of mutation that has been
reported in forward genetic screens using EMS in several
different species [30,32,34]. In C. elegans approximately
7% of all mutations from forward genetic screens of EMS-
treated animals are deletions (Additional File 1). We did
not identify any deletions in this TILLING project but we
are confident (based on previous studies [23,36]) that if
EMS does generate this type of mutation in C. elegans,
TILLING will be able to detect these events as well as the
single base pair changes that are more common. The rea-
son that deletions have been identified more frequently in
forward genetic screens than in our reverse genetic screen
is probably because these mutations are much more likely
to produce a phenotype than the single bp mutations
more commonly produced by EMS.
Mutagen dose and mutation rate
The dose of EMS used for our TILLING project (0.025M)
was lower than that used in many forward genetic screens
because studies have shown that this lower dose simpli-
fies the identification of mutant phenotypes caused by the
gene of interest while limiting confounding background
phenotypes or lethality [37]. In two strains, however
(CN843 and CN1643), we identified mutations in two
different genes in the same strain. While this might seem
to indicate a very high overall mutation frequency, we do
not believe that this is the case since the mutagenised ani-
mals seem healthy and fertile, and since the overall muta-
Outline of C. elegans TILLING procedure Figure 2
Outline of C. elegans TILLING procedure. Animals are mutagenised with EMS, picked individually to plates, and allowed to self. 
One third of the worms are used for DNA and the remaining two thirds are frozen for future analysis. DNA is pooled 8-fold 
to reduce time and expense. TILLING is performed in order to determine which individuals carry mutations in the gene of 
interest. Mutations are sequenced and individuals from lines carrying mutations that have an effect on the gene product are 
thawed and genotyped to isolate heterozygous or homozygous mutants.
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Table 2: Mutations identified by TILLING.
Gene Strain Allele Change Effect
C05C10.5 CN556 vc21 C112T P23S
C05C10.5 CN1688 vc40 G178A G45R
C05C10.5 CN1746 vc41 G230A Non-coding
mel-32 C05D11.11 CN843 vc11 G361A V106I
mel-32 C05D11.11 CN1181 vc68 C1339T Q416*
mel-32 C05D11.11 CN1621 vc69 G289A G82R
mel-32 C05D11.11 CN1665 vc70 G373A D110N
mel-32 C05D11.11 CN1738 vc71 G384A K113=
mel-32 C05D11.11 CN1805 vc72 G972A K293=
mel-32 C05D11.11 CN1856 vc73 G373A D110N
mus-81 C43E11.2 CN1162 vc42 C1830T L368F
mus-81 C43E11.2 CN1162 vc43 G1231A Non-coding
mus-81 C43E11.2 CN1211 vc44 A955T Non-coding
mus-81 C43E11.2 CN1456 vc45 G972A Non-coding
mus-81 C43E11.2 CN1604 vc46 G1897A G390E
mus-81 C43E11.2 CN1766 vc47 C1687T T320I
mus-81 C43E11.2 CN568 vc48 G1313A D214N
xpf-1 C47D12.8 CN665 vc18 C602T L183F
xpf-1 C47D12.8 CN720 vc19 G930A R292H
xpf-1 C47D12.8 CN1286 vc62 G1036A R278Q
xpf-1 C47D12.8 CN1475 vc63 G446A E100K
xpf-1 C47D12.8 CN1574 vc64 C101T Non-coding
xpf-1 C47D12.8 CN1574 vc65 G818T S205=
xpf-1 C47D12.8 CN1751 vc66 C902T V233=
xpf-1 C47D12.8 CN1798 vc67 G942A D247N
F25H2.13 CN838 vc10 A1200T I277F
F25H2.13 CN1245 vc52 G1206A E279K
F25H2.13 CN1326 vc53 G421A Non-coding
F25H2.13 CN1742 vc54 G285A E95=
F25H2.13 CN1812 vc55 G399A Non-coding
F25H2.13 CN1838 vc56 G1167A A266T
F25H2.13 CN579 vc7 C649T Non-coding
F25H2.13 CN579 vc8 C1165T S265F
F25H2.13 CN48 vc9 G1242A E291K
htp-3 F57C9.5 CN646 vc1 G2224A E616K
htp-3 F57C9.5 CN823 vc13 G1785A E469=
htp-3 F57C9.5 CN727 vc2 G2029A E551K
htp-3 F57C9.5 CN1362 vc23 C2048T P557L
htp-3 F57C9.5 CN1369 vc24 G1905A S509=
htp-3 F57C9.5 CN1425 vc25 G2181A Q601=
htp-3 F57C9.5 CN1630 vc26 G2230A V618I
htp-3 F57C9.5 CN1723 vc27 C1245T P306L
htp-3 F57C9.5 CN1735 vc28 C2331T Y651=
htp-3 F57C9.5 CN825 vc3 G1333A R335=
M03C11.2 CN1246 vc57 G4804A E680K
M03C11.2 CN1479 vc58 G5097A G725D
M03C11.2 CN1543 vc59 C4755T I663=
M03C11.2 CN1643 vc60 C4739T P658L
M03C11.2 CN1712 vc61 C5740T H782Y
Cki-2 T05A6.2 CN843 vc20 C413T T123I
Cki-2 T05A6.2 CN1157 vc31 G869A Non-coding
Cki-2 T05A6.2 CN1231 vc32 C338T T98I
Cki-2 T05A6.2 CN1254 vc33 G214A G57R
Cki-2 T05A6.2 CN1309 vc34 G524A E146K
Cki-2 T05A6.2 CN1364 vc35 G876A Non-coding
Cki-2 T05A6.2 CN1575 vc36 G370A V109M
Cki-2 T05A6.2 CN1643 vc37 C170T S42F
Cki-2 T05A6.2 CN1672 vc38 G148A E35K
Cki-2 T05A6.2 CN1787 vc39 G76A Splice JunctionBMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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tion rate was calculated to be one mutation every 293 kb
(71 mutations in 14225 bp of DNA from 1464 animals).
This is not significantly higher than the rate of one muta-
tion in 300 kb seen for TILLING in Arabidopsis [23], and is
lower than the rate of one mutation in 156 kb reported for
Drosophila [29]. Hence, the 0.025M dose of EMS appears
to be an adequate dose for TILLING based on comparison
with these other systems in which this technique is cur-
rently being used.
Effects of mutations identified through TILLING
The spectrum of mutations identified through forward
and reverse screens using EMS, although similar at the
level of DNA sequence is much different when the effects
of the mutations are compared. Of the 194 single bp
mutations we analysed from Wormbase (Additional File
1) 50% resulted in missense alleles and the remaining
50% in nonsense or splice junction mutations. In our
TILLING screen, because the selection of mutants was not
based on phenotype, 38% of the mutations we identified
are predicted to be silent. These include mutations in
introns and intergenic regions and mutations that alter
the third bp of a codon such that it still encodes the
wildtype amino acid. The majority of the mutations we
identified (59%) were missense alleles that alter the
amino acid sequence of the protein encoded by the target
gene (Table 2). Of the 42 missense mutations identified in
our screen, 17 of these may not have a significant effect on
phenotype since the amino acid mutated was replaced by
an amino acid of similar charge and polarity, but the 25
remaining missense mutations are predicted to signifi-
cantly affect the structure of the protein product of the tar-
get gene by changing the charge or hydrophobicity of this
region of the protein.
Two of the mutations identified in our TILLING screen,
mel-32  C05D11.11(vc68)  and  cki-2  T05A6.2(vc39), are
predicted to result in a complete loss-of-function, or null,
phenotype because they truncate the protein product of
the gene. One of these introduces a premature stop codon
into the third exon of gene mel-32 C05D11.11, and the
other is a splice junction mutation that eliminates the
splice donor site of first intron of the gene cki-2 T05A6.2
(Figure 3). The proportion of putative null mutations
identified in our screen was 3% which is not significantly
different than the frequency of 2% seen in the Drosophila
TILLING study published [29] or than the 5% reported
from the much larger Arabidopsis  TILLNG project [23].
This frequency is higher than would be expected using
other chemical mutagens in C. elegans such as ENU [38]
which cause a different spectrum of mutagenic events that
are more likely to result in missense than nonsense muta-
tions.
Pooling and library construction
A frozen library of approximately 1500 individual EMS-
treated lines of C. elegans was constructed for this study
(Figure 2), and DNA was isolated, purified, and arrayed in
pools of eight as has been shown to work for TILLING in
other diploid species such as Arabidopsis thaliana [22],
Lotus japonicas [24], Zea maize [27] and Brassica oleracea
[Gilchrist and Haughn, unpublished]. Purification of the
DNA was found to be necessary both because the TILLING
reactions did not work on unpurified DNA samples and
because accurate quantitation of the samples is essential
before pooling so that DNA from mutant animals is suffi-
ciently represented in the 8-fold pools [27]. Both 4-fold
and 12-fold pools were tested in C. elegans in order to con-
firm that 8-fold pooling would be efficient (see Materials
and Methods for details). With 4-fold pooling all of the
mutant bands were detected, as they were with the 8-fold
pools, whereas with 12-fold pooling only a subset of the
mutant bands were seen on the TILLING gel. Although 10-
fold pools might be possible in C. elegans given that the
genome size of this organism is slightly smaller than Ara-
bidopsis, the construction of libraries for screening in 96 or
mdf-2 Y69A2AR.30 CN711 vc15 G243A D65N
mdf-2 Y69A2AR.30 CN902 vc17 C1083T Non-coding
mdf-2 Y69A2AR.30 CN1613 vc49 C838T Non-coding
mdf-2 Y69A2AR.30 CN1703 vc50 C838T Non-coding
mdf-2 Y69A2AR.30 CN1865 vc51 C520T Non-coding
mdf-2 Y69A2AR.30 CN1114 vc74 G76A Non-coding
htp-2 Y73B6BL.2 CN750 vc14 C507T A139V
htp-2 Y73B6BL.2 CN50 vc22 C756T T222I
htp-2 Y73B6BL.2 CN1271 vc29 C712T S207=
htp-2 Y73B6BL.2 CN1540 vc30 G345A R85Q
htp-2 Y73B6BL.2 CN574 vc5 G49A D17N
htp-2 Y73B6BL.2 CN901 vc6 G878A G263R
One letter nucleotide and amino acid codes follow IUPAC-IUB nomenclature. The first letter in the Nucleotide Change column indicates the 
wildtype nucleotide at this site, followed by the position of the mutation from the start codon in the genomic DNA and then the mutant nucleotide. 
The first letter in the Effect column indicates the wildtype amino acid at this site, followed by the position of the mutation within the predicted 
protein sequence and then mutated amino acid. An equal sign after the amino acid position means no change in the amino acid encoded by that 
codon, and an asterisk indicates a stop codon. Mutations in introns and intergenic regions are designated "Non-coding".
Table 2: Mutations identified by TILLING. (Continued)BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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384-well plates dictates that pooling is only efficient in
multiples of eight or 12, and since mutations are missed
with 12-fold pooling in C. elegans, libraries constructed
for this TILLING study were pooled in 8-fold aliquots.
Our first library consisted of 696 rather than the planned
768 (8 × 96) mutagenised worms because the DNA qual-
ity in 72 of the 768 lines established was too poor to be
used for TILLING. Only 8-fold column pools were con-
structed for this library and when a mutation was detected
in a column pool well, each of the eight individuals that
made up that pool was examined by TILLING in order to
determine which strain carried the mutation. For the sec-
ond library of 768 animals, however, both 8-fold row
pools and 8-fold column pools were constructed and
screened. The DNA from individual worms was arrayed in
12, eight-by-eight grids so as to simplify pooling in either
direction. Then the DNA was pooled by combining sam-
ples from one row or one column into a single pool,
resulting in a total of 96 pools. The identity of the strain
carrying a mutation detected on the TILLING gels was
computed automatically by cross-referencing the data
from the row and column pools.
In theory, the method used for screening library #1 only
required an average of 120 reactions: one 8-fold column
pool, plus eight individuals for each of three mutations
detected (24 additional reactions). However, the 24 reac-
tions done to determine which individual from a pool car-
ried the mutation had to be set up manually and often
needed to be repeated in order to ensure that all of the
reactions worked. Thus, this pooling strategy was more
time-consuming and often required almost as many TILL-
ING reactions as the screening of both row and column
pools simultaneously. In addition, the row and column
pool strategy allowed false positive bands to be excluded
Gene models depicting the distribution of different types of mutations within the genes Figure 3
Gene models depicting the distribution of different types of mutations within the genes. The figure was designed from PARS-
ESNP [42] output files. Blue lines indicate the extent of the amplified region that was used for TILLING. Orange open boxes 
denote exons. Purple up arrows indicate a change in the DNA sequence that does not affect the amino acid product. Purple 
down arrows indicate a change in non-coding DNA. Black up arrows indicate a change that induces a missense mutation in the 
predicted protein product. Red up arrows indicate a premature stop codon or splice junction error.
T05A6.2a
C05C10.5a
C43E11.2a
M03C11.2
C47D12.8
C05D11.11
F25H2.13
F57C9.5
Y69A2AR.30a
Y73B6BL.2BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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from our study since a mutation was never followed
unless it appeared in at least one channel in both row and
column pool gels.
Selection of targeted regions
Mutations identified through TILLING are randomly dis-
tributed in the genome, thus making it possible to target
genes of any size and at any location [23]. The average size
of the region that is tested in one TILLING screen is usu-
ally about 1500 bp and this is the size that was used for
most genes in this study (Table 1). For the gene C05C10.5
whose genomic sequence is only 788 bp we designed
primers that amplified a region of approximately 1200 bp
to avoid screening excess intergenic DNA upstream or
downstream of the locus where mutations would have a
higher probability of being silent. In addition, for gene
mus-81  C43E11.2, the primer sets that we designed to
amplify a product of 1500 bp gave multiple amplification
bands when used with our standard PCR conditions. Thus
we were forced to use a primer set that amplified a smaller
region in order to obtain a single, clean PCR product from
this locus.
For genes that are much larger than 1500 bp, two
approaches have been used for TILLING in other systems.
The web-based programme, CODDLE [39] was originally
designed for use in the Arabidopsis thaliana TILLING
project and assists researchers in designing primers to
select regions of a gene of interest that are most likely to
provide loss-of-function or deleterious alleles. Researchers
also have the option of requesting that CODDLE design
primers that will amplify a fragment within a specific
region of the gene in which they are most interested, for
example, a specific domain that is known to interact with
another gene or protein. A different approach was used for
a recent Drosophila melanogaster TILLING project [29]. In
this study, multiple primers were designed to amplify
overlapping fragments of a gene so that the entire gene
could be screened by TILLING. For our TILLING project in
C. elegans, as mentioned previously, the average amplicon
size was 1500 bp and primers were designed to amplify
the region of the gene predicted by CODDLE to be most
susceptible to EMS-induced mutations. Primer sequences
used in this study are listed in Table 3. For C. elegans,
where the average gene size is 3000 bp and introns are
generally small [40], TILLING should prove to be even
more efficient than in other species where larger genes
and intervening sequences are the norm. Indeed, 62% of
mutations recovered in this C. elegans screen are predicted
to have an effect on the protein product (Table 2),
although long-term studies are required to determine
exactly how many of these mutations will result in a
mutant phenotype.
Identification of individual mutant animals
Each F1 mutagenised line was frozen individually in order
to ensure that identified mutations could be recovered
even if a sample was frozen and thawed multiple times
(see Figure 2). Except in the case of deleterious mutations
that affect viability or reproduction, each mutant allele
that is heterozygous in the F1 parent is expected to be
present in 3/4 of the progeny of this individual. If the
mutant allele is recessive lethal, then the frequency of
progeny carrying this allele should be 2/3. In this study we
Table 3: Primers used to amplify target genes in pilot C. elegans TILLING project
Gene Oligo Name Oligo Sequence
F57C9.5 ce0001Lb GTGCTGAGAATCCTGAACTTGACG
ce0001R TCTACTTGGCATGTTCGGCGACTG
Y73B6BL.2 ce0002L GGGTTCGCGAATTTCACTTGCATT
ce0002R CGGCTCCTCTGCGAGTAGTTGGTC
T05A6.2 ce0003L GCGGCGCACTCACATTTTTCTCTT
ce0003R CTGTGCGGACTTTGGCACATTTGA
C05C10.5 ce0004L GAACTATTTGTGCGCGCGCGTTT
ce0004R TCAATGAGTGGGGTGGATTCAAGAAGA
C43E11.2 ce0006-3L CTCCGAAATGAGAACTGTCCGACCAAT
ce0006-3R AAAGCTGAAGAAGTCGAATCGGTGCAT
Y69A2AR.30 ce0007L CGCGATTTCCCTCAAAGGATCTGC
ce0007R AGAGCACCATCACACCACCTGACG
F25H2.13 ce0008L TCAAAAAGAGACGAAGCCGCTGGA
ce0008R GCAGCAGCAACATCTTGAGCGTGT
M03C11.2 ce0009-2L CAGCTCAGCTTCTCGTGGAGACCCTAT
ce0009-2R AGGAATCTTTAGAGCAACCGGGCAAAA
C47D12.8 ce0010L CCGGAATCGCATTGATTCCAAAAG
ce0010R TGCAGCGAAATCACTTACAATCGTTTCC
C05D11.11 ce0011L CGCCACAAGTACACCAACAACGAGAA
ce0011R GCGAGATCAGCGACGTCTTTCTTGABMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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were able to recover individual descendants of F2 worms
carrying the mutant alleles in 19 of the 20 strains thawed
for testing. The remaining strain proved to be a false pos-
itive isolated from our screening of our first library. The
probability of this type of error occurring with our current
methodology of screening both row and column pools is
very low.
There are several methods that can be used to follow the
segregation of point mutations in F2 and subsequent pop-
ulations. We used three different strategies for comparison
in this study: TILLING, cleaved amplified polymorphic
sequences (CAPS) [41], and direct sequencing. TILLING
was the most expensive and labour-intensive method
because of the requirement to purify the extracted DNA
for PCR and because detection of homozygous individu-
als necessitated duplexing the DNA from the putative
mutant with wildtype DNA (since fragments are only
cleaved with CJE if there is a mismatch in the DNA). In
addition, multiple rounds of TILLING were sometimes
necessary if one of the two reactions (duplexed and non-
duplexed DNA) failed, because in such a case the zygosity
of the animal in question could not be determined. CAPS
was tried if the PARSESNP programme ([42] indicated
one or more restriction enzyme polymorphisms between
the mutant and wildtype sequences (Figure 4). Sixty of the
71 mutations we identified (85%) in this screen are of this
type. For the samples where there were no restriction
enzyme polymorphisms either TILLING or direct
sequencing was used to detect mutant individuals because
of time constraints, although studies have shown that the
derived cleaved amplified polymorphic sequences
(dCAPS) technique works well and would be a less expen-
sive method for following mutations in the long-term
[43].
Results from direct sequencing of DNA from F2 descend-
ants of mutant animals showed that the mutation of inter-
est was present in an average of two out of three of the
thawed progeny (43 out of 64 samples), although this var-
ied from a low of one out of eight with F25H2.13(vc9),
and a high of 13 out of 16 with htp-3 F57C9.5(vc2). Both
of these alleles with non-typical segregation patterns are
missense mutations and, although the vc2 allele does not
have an obvious phenotype in homozygous mutants, we
speculate that it may be incompatible with the wildtype
allele of this locus since heterozygous individuals carrying
both mutant and wildtype alleles together were never
recovered. The high frequency of homozygous vc2
mutants compared to wildtype individuals may just be a
statistical anomaly or may indicate that the mutant pro-
tein confers some type of fitness advantage upon animals
carrying it.
Two other mutations, F25H2.13(vc10)  and  mel-32
C05D11.11(vc11), were apparently homozygous in the
parent F1 strains in which these alleles were detected
because all of the thawed progeny from the F2 plates were
found to be homozygous for these mutations. All other
mutations were heterozygous in the F1  generation, as
expected, because EMS-induced damage in C. elegans usu-
ally occurs in either the P0 egg or the P0 sperm before fer-
tilization. Neither of the homozygous mutations was
present as a background mutation in the wildtype strain
used for mutagenesis, or in any of the other mutant strains
whose DNA was sequenced. The F1 homozygosity of vc10
Restriction enzyme digests of DNA from heterozygous and homozygous mutants Figure 4
Restriction enzyme digests of DNA from heterozygous and homozygous mutants. A) CAPS analysis of sibling lines for CN646 
htp-3(vc1) using the restriction enzyme Taq1. The lanes labelled N2 are wildtype controls. Lane marked 4 exhibits additional 
bands when digested with this enzyme indicating this line is heterozygous for the vc1 mutation. B) CAPS analysis of sibling lines 
for CN711 mdf-2(vc15), using the restriction enzyme Hinf1. The lanes labelled N2 are wildtype controls. Lanes marked 4, 5 and 
6 show additional cleavage bands and are missing the wildtype band indicating that they are homozygous for the vc15 mutation.
A) B)BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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and vc11 may be the result of an early mitotic crossover or
other heritable event that occurred in the developing
zygote rather than in the maternal germ cells, during or
after EMS mutagenesis. The fact that these mutations were
detectable at all using TILLING is curious since a DNA
mismatch is needed for cleavage with CJE. In the pooled
samples, adequate wildtype DNA from other samples
would have been amplified and paired with the mutant
DNA for cleavage to occur, but when testing the DNA
from the individual F1 animals no wildtype DNA should
have been present since we did not detect any wildtype
progeny from these animals. It is possible that only the
germ cells of the F1 animal carried the mutations identi-
fied in our screen and that wildtype DNA from the
somatic cells of this animal was sufficient to allow for
cleavage with CJE when amplified using PCR. It is also
possible that some wildtype DNA contamination was
present in these reactions and was amplified along with
the homozygous DNA from the mutant. The fact that the
cleavage bands were very faint on the TILLING gels is con-
sistent with either of these ideas.
An additional polymorphism in gene F25H2.13 was iden-
tified when sequencing other alleles of this gene and
found to be homozygous in all TILLING strains and in the
N2 P0 strain utilised for mutagenesis in this study, making
it clear that this strain is different from the N2 strain used
in the C. elegans genome sequencing project. Although
this polymorphism induces an amino acid change in the
protein sequence, it has no obvious effect on gene func-
tion since animals carrying the polymorphism are seem-
ingly wildtype.
Analysis of mutants identified through TILLING
Some of the loci chosen as candidates for this pilot project
were genes that are thought to play roles in chromosome
segregation, recombination or genome maintenance. In
some cases, RNAi constructs of these genes had been
shown to induce varying phenotypes, and we reasoned
that null and missense alleles of these targets would allow
us to better identify the true function of these genes. In
other cases, the genes we targeted had no known RNAi
phenotype, but had been implicated in meiotic functions
through two-hybrid or bioinformatics studies.
Examination of the sequence of the 71 alterations shown
in Table 2 revealed that 27 of the changes resulted in no
amino acid change (silent mutations) and these strains
are unlikely to have visible phenotypes. Of the remaining
44 mutations resulting in amino acid changes, 24 affected
charged or conserved residues. These are the alleles that
are most likely to affect the functioning of the gene prod-
uct and thus most likely to have phenotypic changes. We
have done preliminary phenotypic analysis on 25 of the
TILLING alleles we identified and observed phenotypes
for 16 of these alleles. Although further studies are needed
to confirm these data, the TILLING alleles reported here
clearly allow characterisation of these genes in a manner
that was not previously possible.
mel-32 C05D11.11
The gene, mel-32 C05D11.11 was selected simply as a con-
trol because many mutations at this locus have been iden-
tified through forward genetic screens and sequencing of
these indicates that most of the amino acids in the
encoded protein are essential for normal gene function
[46]. Mutations in this gene result in a maternal-effect
lethal phenotype (Mel). The homozygotes are viable and
fertile, but produce eggs that fail to hatch. The putative
null allele isolated by TILLING (vc68) does indeed have a
Mel phenotype. The three remaining missense alleles are
currently being examined, although preliminary evidence
indicates that one of them (vc11) is a conservative change
that does not appear to confer any mutant phenotype.
C05C10.5
A gene name has not yet been assigned for this locus (indi-
cated by * in Table 1). Little is known about this gene or
the function of the gene product. RNAi treatment pro-
duces variable results ranging from embryonic lethality to
high incidence of males (Him). We have two TILLed alle-
les (vc21 and vc40) that were isolated as heterozygotes and
are being maintained as such. As a consequence we have
not yet determined whether or not these alleles will cause
a mutant phenotype.
mus-81 C43E11.2
We have isolated the first genetic mutations in this gene
through TILLING. Three of the missense mutations (vc42,
vc46 and vc47) have a radiation-sensitive (Rad) pheno-
type. The mutant strains, which can be maintained as
homozygotes, vary in the severity of their response to radi-
ation, and thus will provide valuable resources for dissect-
ing the molecular characteristics of this gene.
Homozygous mus-81(vc46) animals are severely radiation
sensitive, while animals carrying either mus-81(vc42) or
mus-81(vc47) exhibit less severe phenotypes. These phe-
notypes are consistent and continue to segregate with the
molecular mutations even after multiple outcrossings.
xpf-1 C47D12.8
This gene is the C. elegans orthologue of the essential
nucleotide excision repair gene XPF/ERCC4 [48]. We have
identified three mutations in this gene (vc18, vc19 and
vc67). All of these are missense alleles, and we have deter-
mined that two of them (vc19 and vc67), have a Rad phe-
notype as would be predicted. None of the alleles is lethal
since they can be maintained as homozygotes.BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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F25H2.13
A gene name has not yet been assigned for this locus (indi-
cated by * in Table 1), but it is predicted to encode a
DEAD helicase closely related by sequence to DOG-1.
RNAi treatment reveals no detectable phenotype and the
deletion allele (tm1866) is listed in Wormbase [7] as
homozygous viable. We have identified five new missense
alleles through TILLING, and strains carrying these alleles
are also viable although they appear to have reduced
brood sizes.
htp-3 F57C9.5
Excellent antibodies are available for studying the protein
product of this HIM-3 paralogue in vivo, but the deletion
allele htp-3(gk26) is associated with a complex rearrange-
ment that includes a wild-type copy of the gene, making
phenotypic analysis impossible. RNAi experiments
revealed that the animals exhibit no phenotype when the
worms are fed a dsRNA construct for htp-3 F57C9.5 [44],
but injection of the dsRNA results in severe embryonic
lethality as a consequence of chromosome nondisjunc-
tion [45]. We have isolated five new missense alleles of
this gene by TILLING, and observed varying levels of
embryonic lethality that segregate with the mutant allele
for three of these mutations (vc1, vc75 and vc77).
M03C11.2
A gene name has not yet been assigned for this locus (indi-
cated by * in Table 1), but the gene is a member of the
DEAD helicase family related to DOG-1. RNAi treatment
produces arrested embryos, and a deletion allele (tm2188)
has been shown to be sterile, but we have not yet deter-
mined whether any of the missense alleles we have iden-
tified by TILLING have phenotypes.
cki-2 T05A6.2
The knockout allele of this gene cki-2(ok741) causes steril-
ity in homozygous animals as does the TILLING mutation
cki-2(vc39) which affects a conserved splice junction site.
The strain is easily maintained as a heterozygote, however,
and can used for genetic analysis in this way.
mdf-2 Y69A2AR.30
This gene was studied previously using RNAi and shown
to have reduced brood size and increased incidence of
males [47]. Using TILLING, we have successfully identi-
fied the first genetic mutation in this gene. The mdf-
2(vc15)  mutation can be maintained homozygously
despite exhibiting reduced brood size and high incidence
of males, and thus provides a valuable tool for the study
of metaphase to anaphase checkpoint signalling.
htp-2 Y73B6BL.2
This gene encodes a paralogue of HIM-3 and has been
shown to play a role in meiotic function. RNAi treatment
produces a Him phenotype. We have five TILLed alleles of
this locus that are viable as homozygotes and for which
we have observed no obvious phenotype.
One of the major advantages of TILLING is that it can not
only identify null mutations which eliminate the function
of the gene product entirely, but also missense alleles that
result in a partial loss or change of gene function and
which can allow disruption of specific domains within a
gene and are especially useful for suppressor screens
which can be used to identify interacting genes. The
reverse genetic techniques that are presently being used in
C. elegans are all more likely to result in complete-loss-of-
function alleles which, if the effect is lethal or detrimental,
may limit the analysis that can be done. With TILLING,
however, it is possible to use missense mutations in differ-
ent regions of the gene for the dissection of multiple func-
tions and interactions of a given gene product. While the
point mutations that TILLING identifies can result in
complete loss-of-function alleles that are as effective as
deletions in knocking out gene function, this technique
can also identify partial loss-of-function alleles or other
alterations of gene function that can be extremely useful
for investigating the function of essential genes or genes
encoding proteins with multiple domains. A well-known
example illustrating the value of an allelic series of muta-
tions is the elucidation of the functions of the let-60 gene
of C. elegans which encodes a member of the GTP-binding
RAS proto-oncogene family involved in signalling
(reviewed in [49]. Different mutations in this gene can
have recessive, semi-dominant, or dominant phenotypes
that define functions for the protein in developmental
processes as diverse as vulval induction, migration of the
sex myoblasts, function of chemosensory neurons, pro-
gression through pachytene in meiosis I, and differentia-
tion of the excretory cell. Thus, a comprehensive
understanding of the biology of a given gene is often
revealed using non-null mutations. In this study we have
identified 42 new missense mutations and two nonsense
mutations that are available for genetic studies, and pre-
liminary analysis indicates that at least some of these have
deleterious effects on phenotype.
Conclusions
We have used TILLING in C. elegans to determine the spec-
trum of mutations induced by EMS in this species and
found that 96% of the mutations we identified were G/C-
to-A/T transitions. In this pilot project we identified 71
point mutations in 10 genes, of which 44 or more may
have an effect on gene function. For seven of the genes we
targeted no mutant strains were previously available from
the Caenorhabditis Stock Centre. One of the remaining tar-
get genes had a deletion mutation, but the strain carrying
this mutation was shown to also carry a wildtype copy of
the gene. Hence, for eight of the 10 target genes screened,BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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TILLING has provided the first genetically heritable muta-
tions which can be used to study their functions in vivo.
A frozen library of more than 1500 EMS-mutagenised
worms was constructed, and enough DNA has been
extracted and purified to screen for mutations in more
than 5000 genes. The initial construction of the mutant
library is labour-intensive but, if well-constructed, it
should only be necessary to perform this step once.
Approximately one gene, per Li-cor sequencer, per week
can be screened after library construction is complete. The
cost and rate of TILLING is dependent partially on the
quality of the DNA being screened (how reliably the reac-
tions work) and the mutation rate (how many alleles are
identified per pooled population). Current estimates of
cost-per-gene vary from $1500 to $2500 USD, including
equipment, labour and consumables.
TILLING appears to provide a reasonably high proportion
of missense mutations in C. elegans probably, in part,
because of the small size of C. elegans introns compared to
some other species. With EMS, the expected frequency of
nonsense and splice junction mutations from TILLING
screens is approximately five percent in most species. The
two putative null alleles of this type that we have identi-
fied (out of 71 mutations) represent a frequency not sig-
nificantly different from the expected five percent. At the
CAN-TILL facility TILLING is successfully being used in
many species for the detection of both induced and natu-
ral variation (reviewed in [50]) and there appears to be no
species bias in terms of performance. It would seem, how-
ever, to be especially useful for genetically tractable organ-
isms such as C. elegans where genomics tools are well
developed, but where reverse genetics techniques that can
provide heritable mutations suitable for genetic analysis
lag far behind.
Methods
Mutagenesis and library construction
N2 wild type hermaphrodites were exposed to 0.025 M
EMS for 4 h (as in Brenner, 1974 [51], but at a lower EMS
concentration). After exposure to mutagen, the worms
were washed and allowed to recover for 1–2 h before
young gravid hermaphrodites were picked to fresh plates
(10 per plate). After 24 h, the mutagenised P0 animals
were transferred to fresh plates for a second 24 h brood. F1
progeny were picked 1 per plate and allowed to self-ferti-
lize. The F1 progeny of mutagenised worms were set up
individually rather than in pooled populations so as to
ultimately simplify the isolation of F3 animals carrying
any mutations. This was considerably more work than
would have been required with pooled F1 samples but,
because worm libraries were frozen, the extra work was a
one time occurrence and greatly simplified identification
of thawed mutants. When the mutagenised worm popula-
tions had exhausted the bacteria on the plate, worms were
washed off each plate with 2 ml of M9 buffer. One third
of the population from each F1 line was used for DNA and
the other two thirds was frozen for future use as follows:
from each plate, 0.5 ml of worms were mixed with 0.5 ml
of 2X freeze solution (100 mM NaCl, 50 mM KPO4 pH
6.0, 0.3 mM MgSO4, 30% glycerol) and frozen at – 80°C
to generate a frozen library stock.
The remaining 1 ml of worms in M9 buffer for each line
was centrifuged at 14,000 g to pellet worms. Excess buffer
was aspirated leaving approximately 50 μl of buffer and
worms in each tube. 50 μl of worm lysis buffer (50 mM
KCl, 10 mM Tris (pH 8.3), 2.5 mM MgCl2, 0.45% Noni-
det P-40, 0.45% Tween 20, 0.01% (w/v) gelatin, and 10
mg/ml proteinase K) was added to each tube which was
then frozen at -80°C for at least 1 h. DNA was extracted by
proteinase K lysis at 57°C for 4 h with occasional vortex-
ing, and then 100 μl of phenol:chloroform:isoamyl alco-
hol (24:24:1) solution was added to the crude DNA
extracts and tubes were vortexed for 5 minutes. Phases
were separated by centrifugation at 14,000 g for 5 minutes
and then aqueous layer was removed to a fresh tube con-
taining 100 μl of chloroform, vortexed for 5 minutes and
the phases separated by centrifugation at 14,000 g. The
aqueous layer was again removed to a fresh tube contain-
ing 400 μl of isopropanol, and then the DNA was precip-
itated by centrifugation at 14,000 g for 10 minutes. DNA
pellets were washed once with 70 % ethanol, resuspended
in 50 to 100 μl ddH2O and quantified using a ND-1000
Spectrophotometer (NanoDrop Technologies, Wilming-
ton, DE, USA). Samples were diluted to 1 ng/ul in 10 mM
Tris, 1 mM EDTA pH 7.4, and 1 ml aliquots were distrib-
uted in plates of 64 samples (8 rows by 8 columns) before
pooling. The DNA samples were then pooled 8-fold, in
both column and row directions, and then distributed
into 96-well plates of 8-fold column pools and 96-well
plates of 8-fold row pools for each library of 768 individ-
uals.
Primer design and PCR Amplification
Primers were designed, using the web-based programme
CODDLE [39] and selecting "EMS (not TILLING)" as the
Mutation Method since a C. elegans option was not avail-
able and we did not know how similar the spectrum of
mutations caused by EMS was in C. elegans compared to
other organisms. Primers for C05C10.5 were designed to
amplify a fragment of approximately 1200 bp since the
genomic size of this gene is only 788 bp. The other primer
sets were designed to amplify fragments as close to 1500
bp as possible, given the structure of the DNA in the
region. Primers were purchased from MWG Biotech, Inc.
(High Point, NC, USA), suspended to a concentration of
100 uM in 10 mM Tris, 1 mM EDTA pH 7.4 and used at a
final concentration of 0.2 mM in a mixture of 3:2BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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(labeled:unlabeled) for the forward (IRD700-labeled)
primers and 4:1 (labeled:unlabeled) for the reverse
(IRD800-labeled) primers as per Colbert et al., 2001 [52].
PCR was also performed according to Colbert et al.,2001
[52]: 10 ul PCR reactions with 2.5 ng – 5 ng of genomic
DNA were used for amplification in 96-well or 384-well
PCR plates using ExTaq polymerase (Takara Bio Inc,
Japan), but with 0.6 times the recommended concentra-
tion of ExTaq buffer and 2 mM MgCl2. PCR cycles were as
follows: 95°C for 2 min; eight cycles of [94°C for 20 sec,
73°C for 30 sec (decrementing 1°C per cycle), 72°C for 1
min]; 45 cycles of: [94°C for 20 sec, 65°C for 30 sec, and
72°C for 1 min]; 72°C for 5 min; 99°C for 10 min (dena-
turation and inactivation of taq enzyme); and 70 cycles of
20 sec at 70°C (decrementing 0.3°C per cycle for random
reannealing to allow hybridisation of mutant and
wildtype molecules), hold at 4°C.
Preparation of celery juice extract
Crude celery juice extract (CJE) was prepared as described
by Till et al. [53]. Briefly, 0.5 kg of celery was processed in
a kitchen-quality juicer until liquefied. Tris HCl (pH 7.7)
was added to 0.1 M along with Phenylmethylsulpho-
nylfluoride (PMSF) to 100 mM. The solution was spun at
2600 G for 20 minutes and the supernatant removed,
brought to 25% saturation in (NH4)2SO4, mixed for 30
minutes at 4°C, and spun at 15,000 G for 40 minutes at
4°C. The supernatant was removed again and adjusted to
80% saturation in (NH4)2SO4, mixed for 30 minutes at
4°C, and spun at 15,000 G for 1.5 hours at 4°C. The pellet
from this cut was resuspended in 1/10 the starting volume
of 0.1 M Tris HCl (pH 7.7), 100 mM PMSF. The suspen-
sion was dialysed against 8 L of the same buffer, four
times, for one hour each time at 4°C using Spectrapore
dialysis tubing (10,000 MW cut-off). Aliquots were stored
at -70°C and were spun at approximately 2000 G for one
minute before use to remove any tissue debris.
CJE digestion, sequence analysis and identification of 
mutants
PCR products were digested with CJE by adding 20 μl of
extract and buffer mix (100 mM MgSO4, 100 mM HEPES,
300 mM KCl, 0.02% Triton X-100, 0.002 mg/ml BSA, and
0.2% to 0.3% crude CJE) directly to the PCR reactions and
incubating at 45°C for 15 minutes. Reactions were
stopped by adding 2.5 μl of 0.5 M EDTA. The DNA was
purified by passage through G50 Sephadex in 96-well Mil-
lipore Multiscreen® filtration plates (Millipore Corpora-
tion, Billerica, MA) and concentrated for 30 minutes at
90°C before running on a 25 cm long LI-COR acrylamide
gel with a 0.4 mm wide, 96-well sharkstooth comb. Anal-
ysis of the gel images was done using GelBuddy [54] to
define lanes and estimate sizes of cleavage products. The
correlation of row and pool columns indicated which
individual F1 worm carried the mutation. Most mutations
were sequenced in both directions using either the same
forward or reverse primers as for PCR or an internal
primer designed for sequencing. Sequence analysis was
performed using Sequencher 4.2 (Gene Codes Corpora-
tion, Ann Arbor, MI, USA) and the potential effect of the
mutations was predicted using PARSESNP [42].
Pooling
DNA from 4 strains previously shown to carry a single
mutation each was screened to test the efficiency of differ-
ent pooling depths. Four bands were expected in each of
the two channels of the Li-cor sequencing image when
amplified DNA from these individuals was run on a gel.
With 4-fold pooling all eight mutant bands were detected
(four in the 700 channel image and four in the 800 chan-
nel image), as they were with the 8-fold pools, whereas
with 12-fold pooling, six of the eight mutant bands were
seen on one test gel (three in the 700 channel image and
three in the 800 channel image), and only three bands on
the second gel (two in the 700 channel image and one in
the 800 channel image). Based on these data and data
from other studies, we conclude that 8-fold pooling was
the best option for C. elegans.
Identification of mutant individuals
Frozen worms were thawed and 20 individuals were
plated 1 per 60 mm NGM plate and allowed to self-ferti-
lize. Two approaches were taken to identify lines contain-
ing the target mutation. In the first approach, the 20
individuals from the strain carrying the mutation of inter-
est were plated individually, allowed to grow until plates
were starved, and DNA was prepared as described for the
DNA library construction. In the second approach, indi-
vidual animals from the strain carrying the mutation of
interest were allowed to lay eggs for 2–3 days, and then
the parent was picked into 5 μl of lysis buffer and lysed at
57 °C for 1 h followed by 95 °C for 15 m to inactivate the
proteinase K. In both approaches the extracted DNA was
PCR amplified and the mutation detected either by TILL-
ING, or by direct sequencing of the amplified DNA, or by
digestion of the PCR product with restriction enzymes
resulted in a banding pattern different from wild type.
Restriction enzyme site changes were found by PARSESNP
to occur in 60 of 71 mutations.
If homozygous lines were not identified, 20 more individ-
uals were set up from one line that had been shown to be
heterozygous and the progeny from each of these lines
was screened for evidence of deleterious mutations that
might result in inviability. If sterile adults, dead embryos
or larval lethals were observed, DNA was prepared from
these and tested for the presence of the targeted mutation.
Mutations that segregated with inviable phenotypes were
balanced with genetic balancers to prevent the loss of the
mutation.BMC Genomics 2006, 7:262 http://www.biomedcentral.com/1471-2164/7/262
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Statistical comparison of results from TILLING in different 
organisms
Frequencies of EMS-induced mutations identified during
different TILLING experiments have been based on differ-
ent samples sizes in different species. When comparing
our data with others we used an on-line Proportions Test
[55] to compare the frequencies we observed with those
reported in other species and determine whether or not
observed differences were significant (at the 90% confi-
dence level) or were simply likely to be the result of sam-
ple size differences.
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